MicroPort CardioFlow IPO Initiation: To Save a Life
MicroPort is pre-marketing for an HK IPO to raise $300 million. With a large addressable market opportunity and VitaFlow’s potentially best-in...
955 Views
Microport Cardioflow: Winning in TAVR
We provide our initial thoughts on the proposed listing of medical device (TAVR) company MicroPort Cardioflow on the HKEX.
550 Views
China Healthcare: Macro Themes
This Insight summarizes the takeaways from a recent China healthcare industry conference. There is much talk of pressures on the industry, but...
635 Views
Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?
This article analyzed the market potential of TAVR in China, competition pattern of key players, financial position of MicroPort CardioFlow and...
662 Views
Varian-Siemens Deal: DAX Promotion on the Cards for the Acquirer
This is the largest healthcare sector M&A Deal announced so far in 2020. Earlier this year, in March, Thermo Fisher Scientific Inc (TMO US)...
710 Views